Replies to post #380748 on Innovation Pharmaceuticals Inc (IPIX)

[Lemoncat]

COVID is the immediate focus but the bevy of new potential indications is staggering.

I will be a buyer of bad TLD (huge amount of shares for the money heading into new indications) or a buyer of good TLD (company is derisked - entry price doesn't matter).

Frankly, this week is the only one I'm hesitant to buy. Considerable downside risk on trial failure but I'll be loading the boat at $0.05 or $0.10.

If the TLD is good and I use that same money to buy at $0.80 or $1.20...that's fine when we're destined for $5+.

Go IPIX!